Location: Home
  • search
  • go
  • Relate News
  • 2/11/2025BioKin Pharma's HER2 ADC BL-M07D1 Advances to Phase III in China
  • 2/11/2025Novo Nordisk Reports Strong Growth in China for 2024, Driven by GLP-1 ...
  • 2/11/2025Bio-Thera Enters License Pact with Intas Pharma for Simponi® Biosim...
  • 2/11/2025China's Digital Health Sector Poised for Growth Amid Data Security Con...
  • 2/11/2025JNJ Receives Approval in China for Two Novel BsAbs
  • 2/10/2025NMPA Approves Sinocelltech's Anti-PD-1 Antibody Finotonlimab
  • 2/10/2025Kelun-Biotech's Cetuximab Biosimilar Receives NMPA Approval for First-...
  • 2/10/2025CDE Issues the Technical Guidelines for Writing Biosimilar Drug Packag...
  • 2/7/2025AstraZeneca Reports Strong 2024 Performance Amid China Sales Decline a...
  • 2/7/2025NMPA Announces Package Insert Revision of Gemifloxacin Mesylate Tablet...
  • 2/7/2025Henlius Biotech's Lung Cancer Drug Secures EU Approval
  • 2/7/2025Henlius and Dr. Reddy's Ink Licensing Deal for Daratumumab Biosimilar ...
  • 2/7/2025Recent Executive Moves
  • 2/7/2025Chinese Biotech Firms Cash In On Promising Drug Discoveries Via Licens...
  • 2/7/2025Rapid Trials Prompt Deals Rush for Chinese ‘Super Me-Too’ Drugs (FT)
  • 2/7/2025China's Biopharma Mirrors EV Success (The China Academy)
  • 2/6/2025Merck Halts HPV Vaccine Supply: What It Says about China Market (EGGI)
  • 2/5/2025Trump's Tariffs Threaten Big Pharma With Higher Costs and Slimmer Marg...
  • 2/5/2025NH Reports Latest Data on Chinese Smoking Control Market in MAT 09/202...
  • 2/5/2025MediLink's YL217 received FDA Clearance of IND Application
  • 2/5/2025Merck Faces Growing Challenges in China as Gardasil Sales Stall  
  • 2/5/2025 Pfizer Eyes Expansion in China Amid Pipeline Reshuffle
  • 2/2/2025I-Mab Cuts 27% of Workforce Amid Strategic Shift
  • 2/2/2025FDA Approves XellSmart's IND for iPSC-Derived Cell Therapy in Parkinso...
  • 2/2/2025BeiGene Launches Phase 1 Trial for CLDN6/CD3 BsAb BGB-B455 in Solid Tu...
  • 2/2/2025FDA Approves Minwei Biotech's IND for MWN105
  • 2/2/2025ImmunityBio and BeiGene Partner on Phase 3 Trial of ANKTIVA and PD-1 I...
  • 1/28/2025CStone Partners with SteinCares to Market Sugemalimab in Latin America
  • 1/28/2025China's Evolving Role in Pharma Spurs Regional Realignments, Boosts In...
  • 1/28/2025Akeso's Gumokimab Advances Toward Approval in China for Plaque Psorias...
  • Page:8/356 Total number of articles:10656: [First][<<] [6] [7] [8] [9] [10] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group